IDH1 and acute myeloid leukemia: Here, we evaluated the analytical performance of the Idylla IDH1-2 mutation assay for <i>IDH</i> variant detection using 70 fixed samples from patients with solid tumors and 36 DNA extracts from patients with acute myeloid leukemias previously characterized by NGS +/- IHC.